The prostate is a small gland about the size of a walnut at the base of the abdomen which plays an important role in the production of semen. Most men over the age of 50 experience some problems with their prostate gland. In the UK around 35,000 men are diagnosed annually with this disease and some 10,000 die from the aggressive form of this cancer.
CCRF believes the key to eradicating prostate cancer lies in early detection of a potentially aggressive form of this cancer. If caught early enough this cancer is curable. Current non invasive tests are not sufficiently specific or sensitive enough to detect the early presence of aggressive forms of prostate cancer. However the development of new batteries of tests, called biomarkers, which can detect the tumour fingerprint in blood and urine, show great promise for the early detection and screening for these cancers. Currently we are investigating a new marker for aggressive prostate cancer called PCA3.
Cambridge Cancer Research Fund financially supports research on prostate cancer screening and diagnosis currently underway at Addenbrookes Hospital in Cambridge. This work is made possible by the ever generous support of the people of East Anglia. This is expensive research however, and we now require a broad base of contributors from throughout the country to allow us to expand the various projects. All contributions, large or small would be welcome . Please click on the link opposite to view our latest appeal for this project.